Cambrian BioPharma

Business Services · New York, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

19 Morris Ave, Brooklyn, New York, 11205...

Phone Number

(516) 962-3186

Revenue

$5 Million

Industry

Business Services Research & Development

About Cambrian BioPharma

Cambrian Bio is a biotechnology company focused on developing therapeutics aimed at reversing metabolic decline and dysfunction, which affects a significant portion of the population. Their lead drug candidate, ATX-304, targets the AMPK Network to enhance metabolic rates and address issues related to obesity and aging. The company aims to combat the rising prevalence of chronic diseases linked to metabolic health, which impose a substantial financial burden on the healthcare system. Cambrian Bio's innovative approach seeks to recalibrate cellular signaling pathways to promote healthier aging and overall well-being.Explore more
Cambrian BioPharma's Social MediaSIC Code 87,873NAICS Code 54,541Show more

Cambrian BioPharma Org Chart

James Peyer, Founder, Chief Executive Officer & Board Director at Cambrian BioPharma
United States flag for contact location.

Founder, Chief Executive Officer & Board Dire...

PhoneEmail
Ruth Thieroff-Ekerdt, Chief Medical Officer at Cambrian BioPharma
United States flag for contact location.

Chief Medical Officer

PhoneEmail
William DeVaul, Chief Legal Officer at Cambrian BioPharma
United States flag for contact location.

Chief Legal Officer

PhoneEmail
MK
United States flag for contact location.

Vice President, People & Culture

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JA
United States flag for contact location.

Vice President, Clinical Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Cambrian BioPharma

Compare insights from companies similar to Cambrian BioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Cambrian BioPharma

$5M
11-50
Private
$283.8M
2019
James Peyer, Founder, Chief Executive Officer & Board Director at Cambrian BioPharma
James PeyerFounder, CEO & Board Director
$5.5M
11-50
Private
-
1994
CC
Carolyn CookeOffice Manager
<$5M
11-50
Public
$340.5M
2015
SV
Samara VioletSenior Director, Project Management
<$5M
11-50
Private
$335M
2019
<$5M
11-50
Public
$100.5M
2006
SH
Sudarshan HebbarChief Medical Officer
<$5M
1-10
Private
$142M
2012
Davis Ryman, Chief Medical Officer at Aeovian Pharmaceuticals
Davis RymanChief Medical Officer
<$5M
11-50
Private
$50M
2020
Illustration of an envelope

Cambrian BioPharma Tech Stack

A closer look at the technologies used by Cambrian BioPharma

Top Business Services Companies

Frequently Asked Questions Regarding Cambrian BioPharma

What is Cambrian BioPharma's official website?
Cambrian BioPharma's official website is www.cambrianbio.com
What is Cambrian BioPharma's Revenue?
Cambrian BioPharma's revenue is $5 Million
What is Cambrian BioPharma's SIC code?
Cambrian BioPharma's SIC: 87,873
What is Cambrian BioPharma's NAICS code?
Cambrian BioPharma's NAICS: 54,541
How many employees does Cambrian BioPharma have?
Cambrian BioPharma has 11-50 employees
What industry does Cambrian BioPharma belong to?
Cambrian BioPharma is in the industry of: Business Services, Research & Development
What is Cambrian BioPharma competition?
Cambrian BioPharma top competitors include: Bolt Biotherapeutics, Aeovian Pharmaceuticals, Pappas Ventures companies, Sonoma Biotherapeutics
What technology does Cambrian BioPharma use?
Some of the popular technologies that Cambrian BioPharma uses are: Google Cloud DNS, Google Cloud Platform, Tableau, Power BI
How do I contact Cambrian BioPharma?
Cambrian BioPharma contact info: Phone number: (516) 962-3186 Website: www.cambrianbio.com
What does Cambrian BioPharma do?

Cambrian Bio is a biotechnology company focused on developing therapeutics aimed at reversing metabolic decline and dysfunction, which affects a significant portion of the population. Their lead drug candidate, ATX-304, targets the AMPK Network to enhance metabolic rates and address issues related to obesity and aging. The company aims to combat th... e rising prevalence of chronic diseases linked to metabolic health, which impose a substantial financial burden on the healthcare system. Cambrian Bio's innovative approach seeks to recalibrate cellular signaling pathways to promote healthier aging and overall well-being.Read More

What are Cambrian BioPharma social media links?
Cambrian BioPharma Linkedin page Cambrian BioPharma Twitter page
Who invested in Cambrian BioPharma?
Cambrian BioPharma has 7 investors including Anthos Capital, Moore Capital Management, Future Ventures and Apeiron Investment Group.
Is Cambrian BioPharma a public company?
Cambrian BioPharma is private company therefore does not currently have an official ticker symbol
See more information about Cambrian BioPharma

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.